Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of topical steroids on pharmacokinetics of TW-4752N (rivastigmine patch)
jRCTs041250023Completed
- Sponsor
- Towa Pharmaceutical Co., Ltd.
- Start
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of rivastigmine (2 arms), sponsored by Towa Pharmaceutical Co., Ltd. Primary endpoint: AUC96 of unchanged rivastigmine in plasma. Started May 2025; status: completed.
02
Drugs
rivastigmine
Beyond the preview
Go deeper on jRCTs041250023.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs041250023.